You are viewing: US Oligonucleotide Synthesis Market analysis

The US Oligonucleotide Synthesis Market was valued at $3051.2 Million in 2025 and projected to reach to $7619.7 Million by 2030, representing a compound annual growth rate of 20.1%. The US oligonucleotide synthesis market is poised for exceptional growth through 2030, driven by increasing FDA approvals of nucleotide-based therapeutics and expanding clinical trial pipelines.

US Oligonucleotide Synthesis Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Oligonucleotide Synthesis Market Trends and Insights

  • This represents a compound annual growth rate of 20.1%, significantly outpacing global market trends.
  • The US market benefits from advanced research infrastructure, substantial pharmaceutical R&D investment, and growing adoption of nucleotide-based therapeutics across academic and commercial sectors. Driving this acceleration in the US are increasing applications in gene therapy, antisense oligonucleotide development, and personalized medicine initiatives.
  • The US maintains leadership in synthetic biology and precision therapeutics, with major biotech hubs and contract research organizations scaling production capabilities.
  • Between 2025 and 2030, the US oligonucleotide synthesis market is expected to more than double, reflecting heightened demand from both established pharmaceutical companies and emerging biotech innovators focused on next-generation therapeutic modalities..

Key Market Statistics

  • CAGR (2025-2030) 20.1% CAGR
  • Market Size, 2025 ~USD 3051.2 Million
  • Forecast, 2030 ~USD 7619.7 Million
  • Country US

US Oligonucleotide Synthesis Market Overview

Market Valuation Growth :

The US oligonucleotide synthesis market is valued at $3,051.2 million in 2025 and is projected to reach $7,619.7 million by 2030, representing a 149.6% increase over five years.

Outpacing Global Growth :

The US market CAGR of 20.1% significantly exceeds the global market CAGR of 18.6%, positioning the US as a key growth driver in the oligonucleotide synthesis sector.

Advanced Research Infrastructure :

The US benefits from world-class research institutions, FDA regulatory frameworks, and substantial pharmaceutical R&D investments that accelerate oligonucleotide development and commercialization.

Therapeutic Innovation Pipeline :

Growing adoption of oligonucleotide-based therapeutics for genetic disorders, cancer, and rare diseases is driving demand for specialized synthesis capabilities across US biotech and pharmaceutical companies.

US Oligonucleotide Synthesis Market Dynamics

  • Major pharmaceutical companies and emerging biotech firms are investing heavily in in-house synthesis capabilities and outsourcing partnerships to meet rising demand.
  • The US market's dominance is reinforced by its regulatory expertise, venture capital funding, and concentration of leading research institutions. Key growth catalysts include personalized medicine initiatives, antisense oligonucleotide expansion, and siRNA therapeutic development.
  • Strategic partnerships between contract manufacturing organizations and pharmaceutical companies will further accelerate market penetration.
  • The US is expected to maintain its position as the largest oligonucleotide synthesis market globally, with sustained double-digit growth through the forecast period..

Related Ecosystem

Biotechnology

Top Technologies
    Top Companies

      Key Takeaways

      • The US oligonucleotide synthesis market will grow from $3,051.2M (2025) to $7,619.7M (2030) at a 20.1% CAGR.
      • The US leads in gene therapy and antisense oligonucleotide development, driving market expansion.
      • Advanced research infrastructure and biotech hubs in the US accelerate production and innovation.
      • The US market is expected to more than double in value over the five-year forecast period.

      Oligonucleotide Synthesis Market Report Scope

      Report Metric Details
      Base Year 2025
      Forecast Period 2025–2030
      Growth Rate CAGR of 18.6% from 2025 to 2030
      Market Size Base Year (Billions) ~USD 10.53 (2025)
      Revenue Forecast (Billions) ~USD 24.7 (2030)
      Segments Covered Product, Type, Application, Disease Type, End User

      US Oligonucleotide Synthesis Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Dna Oligos
      • Equipment
      • Oligonucleotide-Based Drugs
      • Other Synthesized Oligos
      • Primers
      • Probes
      • Reagents & Consumables
      • Rna Oligos
      • Synthesized Oligonucleotides

      By Type

      • Antisense Oligonucleotide-Based-Drugs
      • Custom Oligonucleotides
      • Other Oligonucleotide-Based-Drugs
      • Other Research Applications
      • Pcr
      • Predesigned Oligonucleotides
      • Sequencing
      • Sirna Oligonucleotide-Based-Drugs

      By Application

      • Diagnostic Applications
      • Research Applications
      • Therapeutic Applications

      By Disease Type

      • Neurological Disorders
      • Other Diseases
      • Rare Diseases

      By End User

      • Academic Research Institutes
      • Cros & Cmos
      • Diagnostic Laboratories
      • Hospitals
      • Pharmaceutical & Biotechnology Companies

      Target Audience

      • Pharmaceutical Companies : US pharma firms need market data to evaluate oligonucleotide synthesis capabilities, assess outsourcing partnerships, and plan R&D investments in nucleotide-based therapeutic development.
      • Biotech & Specialty Firms : Emerging biotech companies require market insights to validate business models, secure funding, and establish manufacturing partnerships for oligonucleotide-based drug candidates in development.
      • Contract Manufacturing Organizations : CMOs and contract synthesis providers need US market forecasts to identify capacity expansion opportunities, develop service offerings, and target high-growth pharmaceutical and biotech clients.
      • Investment & Venture Capital : Investors and venture firms use market data to evaluate funding opportunities in oligonucleotide synthesis, assess portfolio company growth potential, and identify acquisition targets in the US market.
      • Regulatory & Consulting Bodies : Regulatory agencies, consultants, and policy organizations require market intelligence to understand US oligonucleotide sector trends, inform guidance development, and support strategic planning initiatives.

      Key Companies in the US Oligonucleotide Synthesis Market

      CompanyHQOwnershipStrongest segments
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining, infrastructure, staffing, maintenance),Mission Solutions (government, nuclear remediation, security, logistics, O&M),

      FLUOR CORPORATION

      Fluor Corporation is a publicly traded engineering and construction company founded in 1912 and headquartered in the United States. With approximately 23,000 employees, the company provides design, engineering, procurement, and construction services across multiple industries.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise US market valuation ($3,051.2M in 2025) and verified 5-year forecast data to support investment decisions, business planning, and competitive positioning in the oligonucleotide synthesis sector.
      • Competitive Intelligence : Understand the US market's outperformance versus global trends (20.1% vs 18.6% CAGR) to identify growth opportunities, benchmark performance, and develop targeted market entry or expansion strategies.
      • Regulatory & Infrastructure Insights : Access analysis of US-specific advantages including FDA frameworks, research infrastructure, and R&D investment patterns that drive oligonucleotide synthesis demand and market dynamics.
      • Therapeutic Pipeline Analysis : Leverage detailed insights into US adoption trends for antisense, siRNA, and other oligonucleotide therapeutics to forecast demand for synthesis services and identify emerging market segments.
      • Strategic Partnership Opportunities : Identify key growth drivers and partnership potential with US pharmaceutical companies, biotech firms, and contract manufacturers to capitalize on the expanding oligonucleotide synthesis market.

      Frequently asked questions

      What is the current size of the US oligonucleotide synthesis market?

      The US oligonucleotide synthesis market is valued at $3,051.2 million in 2025.

      What is the projected size of the US market by 2030?

      The US oligonucleotide synthesis market is projected to reach $7,619.7 million by 2030.

      What is the CAGR for the US oligonucleotide synthesis market?

      The US market is expected to grow at a compound annual growth rate of 20.1% from 2025 to 2030.

      What are the primary drivers of growth in the US market?

      Key drivers include increasing applications in gene therapy, antisense oligonucleotide development, personalized medicine, and expanded production capabilities among US biotech firms.

      Why does the US market grow faster than the global average?

      The US benefits from advanced research infrastructure, substantial pharmaceutical R&D investment, major biotech hubs, and early adoption of nucleotide-based therapeutics.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global oligonucleotide synthesis market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      Secondary research was used primarily to identify and collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, the World Health Organization (WHO), the United States Food and Drug Administration (US FDA), the National Center for Biotechnology Information (NCBI), and regulatory body websites, among others. These sources also provided key information on major players, market classification and segmentation aligned with industry trends, regional and country-level markets, market developments, and technology perspectives.

      Primary Research

      In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information. The following is a breakdown of the primary respondents:

      Oligonucleotide Synthesis Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the oligonucleotide synthesis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:

      Oligonucleotide Synthesis Market : Top-Down and Bottom-Up Approach

      Oligonucleotide Synthesis Market Top Down and Bottom Up Approach

      Data Triangulation

      After determining the overall market size through the estimation process, the total market was segmented into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

      Market Definition

      Oligonucleotide synthesis is the chemical process of creating nucleic acid fragments with specific chemical structures or sequences, of varying sizes, to form a desired product. These fragments, known as oligonucleotides, have several applications in medical and life science research. They can be used for DNA sequencing and amplification, detecting complementary DNA or RNA through hybridization, creating artificial genes, and introducing targeted genetic mutations.

      Oligonucleotides are also used to develop therapeutic drugs. These drugs are chemically synthesized and have different mechanisms of action, such as interfering with gene expression, blocking the production of harmful proteins, or restoring the function of mutated genes.

      Key Stakeholders

      • Pharmaceutical & biotechnology companies
      • Hospitals
      • Diagnostic laboratories
      • Academic researchers and government research organizations
      • Private research institutes
      • Custom oligonucleotide service providers
      • Contract manufacturing organizations (CMOs)
      • Oligonucleotide equipment manufacturers
      • Contract research organizations (CROs)
      • Market research & consulting firms
      • Venture capitalists

      Report Objectives

      • To define, describe, and forecast the global oligonucleotide synthesis market based on the offering, type, application, end user, therapeutic area, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall oligonucleotide synthesis market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the oligonucleotide synthesis market
      • To provide information on funding & investment activities, brand/product comparative analysis, vendor valuation, and financial metrics of the oligonucleotide synthesis market

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix gives a detailed comparison of the product portfolios of the top five companies.

      Geographical Analysis

      • A further breakdown of the Rest of Europe’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Asia Pacific’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Latin America’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Middle East’s oligonucleotide synthesis market into countries

      Company Information

      • Detailed analysis and profiling of additional market players (up to five).

       

      Get the Full Oligonucleotide Synthesis Market Report

      Full forecast, segment splits, and company analysis for all Oligonucleotide Synthesis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status